Abstract Details
|
PRESENTER |
No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Elaine Kingwell, MD, PhD (University College London) | No disclosure on file |
| No disclosure on file | |
| John D. Fisk, PhD (Nova Scotia Health) | The institution of Dr. Fisk has received research support from Canadian Institutes of Health Research. The institution of Dr. Fisk has received research support from Multiple Sclerosis Society of Canada. Dr. Fisk has received publishing royalties from a publication relating to health care. |
| No disclosure on file | |
| Charity Evans, PharmD (College of Pharmacy & Nutrition - University of Saskatchewan) | No disclosure on file |
| Robert L. Carruthers, MD | Dr. Carruthers has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Carruthers has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche and Genentech. The institution of Dr. Carruthers has received research support from Roche and Genentech . |
| Ruth-Ann Marrie, MD, PhD (University of Manitoba) | The institution of Dr. Marrie has received research support from CIHR. The institution of Dr. Marrie has received research support from MS Canada. The institution of Dr. Marrie has received research support from National MS Society. The institution of Dr. Marrie has received research support from Crohn's and Colitis Canada. The institution of Dr. Marrie has received research support from US Department of Defense. The institution of Dr. Marrie has received research support from The Arthritis Society. The institution of Dr. Marrie has received research support from CMSC. |
| Helen Tremlett, PhD, BPharm (University of British Columbia) | Dr. Tremlett has nothing to disclose. |